Frederick F. Lang
Affiliations: | Neurosurgery | MD Anderson Cancer Center, Houston, TX, United States |
Google:
"Frederick Lang"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Peshoff MM, Gupta P, Oberai S, et al. (2024) Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma. Neuro-Oncology |
| De A, Lattier JM, Morales JE, et al. (2023) Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative Versus Invasive Cell States in Glioblastoma. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
| Modrek AS, Eskilsson E, Ezhilarasan R, et al. (2022) PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. Frontiers in Oncology. 12: 941657 |
| Lattier JM, De A, Chen Z, et al. (2020) Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment. Oncogene |
| Weathers SP, Penas-Prado M, Pei BL, et al. (2020) Glioblastoma-mediated immune dysfunction limits CMV-specific T cells and therapeutic responses; results from a Phase I/II trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Chen P, Hsu WH, Chang A, et al. (2020) Circadian regulator CLOCK recruits immune suppressive microglia into the GBM tumor microenvironment. Cancer Discovery |
| Weathers SS, Penas-Prado M, Banerjee PP, et al. (2020) A phase I/II clinical trial of autologous CMV-specific T cells in glioblastoma (GBM) patients to reveal a lack of immune effector function. Journal of Clinical Oncology. 38: 2515-2515 |
| Phillips L, Gumin J, Li S, et al. (2020) TMOD-16. A NOVEL ADENOVIRAL-PERMISSIVE, IMMUNOCOMPETENT HAMSTER GLIOMA MODEL TO EVALUATE ONCOLYTIC ADENOVIRAL THERAPY Neuro-Oncology. 22: ii231-ii231 |
| Srinivasan VM, Lang FF, Chen SR, et al. (2019) Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors. Journal of Neurointerventional Surgery |
| Srinivasan VM, Gumin J, Camstra KM, et al. (2019) Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells. Journal of Neurosurgery. 1-9 |